Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond

V Boldescu, MAM Behnam, N Vasilakis… - Nature Reviews Drug …, 2017 - nature.com
Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging
Zika virus, are an increasing and probably lasting global risk. This Review summarizes and …

SF1 and SF2 helicases: family matters

ME Fairman-Williams, UP Guenther… - Current opinion in …, 2010 - Elsevier
Helicases of the superfamily (SF) 1 and 2 are involved in virtually all aspects of RNA and
DNA metabolism. SF1 and SF2 helicases share a catalytic core with high structural …

Conventional and unconventional mechanisms for capping viral mRNA

E Decroly, F Ferron, J Lescar, B Canard - Nature Reviews Microbiology, 2012 - nature.com
In the eukaryotic cell, capping of mRNA 5′ ends is an essential structural modification that
allows efficient mRNA translation, directs pre-mRNA splicing and mRNA export from the …

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug

E Mastrangelo, M Pezzullo… - Journal of …, 2012 - academic.oup.com
Objectives Infection with yellow fever virus (YFV), the prototypic mosquito-borne flavivirus,
causes severe febrile disease with haemorrhage, multi-organ failure and a high mortality …

The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development

D Luo, SG Vasudevan, J Lescar - Antiviral research, 2015 - Elsevier
The flavivirus NS3 protein is associated with the endoplasmic reticulum membrane via its
close interaction with the central hydrophilic region of the NS2B integral membrane protein …

Current trends and limitations in dengue antiviral research

JO Obi, H Gutiérrez-Barbosa, JV Chua… - Tropical Medicine and …, 2021 - mdpi.com
Dengue is the most prevalent arthropod-borne viral disease worldwide and affects
approximately 2.5 billion people living in over 100 countries. Increasing geographic …

Ten years of dengue drug discovery: progress and prospects

SP Lim, QY Wang, CG Noble, YL Chen, H Dong, B Zou… - Antiviral research, 2013 - Elsevier
To combat neglected diseases, the Novartis Institute of Tropical Diseases (NITD) was
founded in 2002 through private–public funding from Novartis and the Singapore Economic …

Structural insights into RNA recognition by RIG-I

D Luo, SC Ding, A Vela, A Kohlway, BD Lindenbach… - Cell, 2011 - cell.com
Intracellular RIG-I-like receptors (RLRs, including RIG-I, MDA-5, and LGP2) recognize viral
RNAs as pathogen-associated molecular patterns (PAMPs) and initiate an antiviral immune …

[HTML][HTML] Structure and functionality in flavivirus NS-proteins: perspectives for drug design

M Bollati, K Alvarez, R Assenberg, C Baronti, B Canard… - Antiviral research, 2010 - Elsevier
Flaviviridae are small enveloped viruses hosting a positive-sense single-stranded RNA
genome. Besides yellow fever virus, a landmark case in the history of virology, members of …

Molecular mechanisms of antiviral agents against dengue virus

MF Lee, YS Wu, CL Poh - Viruses, 2023 - mdpi.com
Dengue is a major global health threat causing 390 million dengue infections and 25,000
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …